Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurologic controls

Moses Rodriguez; Daniel R. Wynn; Teresa K. Kimlinger; Jerry A. Katzmann

doi:10.1212/wnl.40.5.855

Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurologic controls

Moses Rodriguez, Daniel R. Wynn, Teresa K. Kimlinger, Jerry A. Katzmann

Neurology

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

We measured the concentration of C9 in the CSF and plasma of 93 consecutive patients referred for CSF examination in an outpatient multispecialty clinic. We noted no differences in CSF C9 or C9 index between patients with multiple sclerosis and neurologic controls.

Original language	English (US)
Pages (from-to)	855-857
Number of pages	3
Journal	Neurology
Volume	40
Issue number	5
DOIs	https://doi.org/10.1212/wnl.40.5.855
State	Published - May 1990

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/wnl.40.5.855

Cite this

@article{dc0b1483b80f4bcbbe642d5874ed57c2,

title = "Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurologic controls",

abstract = "We measured the concentration of C9 in the CSF and plasma of 93 consecutive patients referred for CSF examination in an outpatient multispecialty clinic. We noted no differences in CSF C9 or C9 index between patients with multiple sclerosis and neurologic controls.",

author = "Moses Rodriguez and Wynn, {Daniel R.} and Kimlinger, {Teresa K.} and Katzmann, {Jerry A.}",

year = "1990",

month = may,

doi = "10.1212/wnl.40.5.855",

language = "English (US)",

volume = "40",

pages = "855--857",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

TY - JOUR

T1 - Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurologic controls

AU - Rodriguez, Moses

AU - Wynn, Daniel R.

AU - Kimlinger, Teresa K.

AU - Katzmann, Jerry A.

PY - 1990/5

Y1 - 1990/5

N2 - We measured the concentration of C9 in the CSF and plasma of 93 consecutive patients referred for CSF examination in an outpatient multispecialty clinic. We noted no differences in CSF C9 or C9 index between patients with multiple sclerosis and neurologic controls.

AB - We measured the concentration of C9 in the CSF and plasma of 93 consecutive patients referred for CSF examination in an outpatient multispecialty clinic. We noted no differences in CSF C9 or C9 index between patients with multiple sclerosis and neurologic controls.

UR - http://www.scopus.com/inward/record.url?scp=0025272273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025272273&partnerID=8YFLogxK

U2 - 10.1212/wnl.40.5.855

DO - 10.1212/wnl.40.5.855

M3 - Article

C2 - 2330118

AN - SCOPUS:0025272273

SN - 0028-3878

VL - 40

SP - 855

EP - 857

JO - Neurology

JF - Neurology

IS - 5

ER -

Terminal component of complement (C9) in the cerebrospinal fluid of patients with multiple sclerosis and neurologic controls

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this